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Orientia tsutsugamushi,	which	requires	specialized	facilities	
for	 culture,	 is	 a	 substantial	 cause	 of	 disease	 in	Asia.	We	
demonstrate	that	O. tsutsugamushi	numbers	increased	for	
up	to	5	days	in	conventional	hemocultures.	Performing	such	
a	culture	step	before	molecular	 testing	could	 increase	the	
sensitivity	of	O. tsutsugamushi	molecular	diagnosis.
Orientia tsutsugamushi, the causative agent of scrub ty-phus, has long been a pathogen of major public health 
concern in the Asia-Pacific region (1,2). Reports from In-
dia, China, and Southeast Asia suggest that a substantial 
proportion of fevers and central nervous system infections 
are caused by this bacterium (3,4). The World Health Orga-
nization has called scrub typhus “probably one of the most 
underdiagnosed and underreported febrile illnesses requir-
ing hospitalization in the region” (5). Furthermore, Ori-
entia-infected patients are emerging outside the so-called 
tsutsugamushi triangle, from the Middle East, Africa, and 
South America (6–8). Orientia spp. DNA was recently de-
tected in rodents from Asia, Europe, and Africa (9). 
To improve patient management and clarify the epide-
miology and pathogenicity of O. tsutsugamushi, physicians 
and researchers need sensitive and specific diagnostic tools 
(10). The current diagnostic reference standard is a 4-fold 
antibody rise between acute- and convalescent-phase se-
rum samples; however, because results are determined ret-
rospectively, they cannot influence patient management. O. 
tsutsugamushi is an intracellular pathogen, and tradition-
ally its growth has been assumed to require specialized cell 
culture at Biosafety Level 3, which is only available at a 
limited number of specialized centers. Therefore, molecu-
lar detection of O. tsutsugamushi in patients’ EDTA-blood 
buffy coat has become the tool of choice for routine diag-
nosis and epidemiologic studies (11,12). In other pathogens 
with low bacterial loads, propagation of the organism be-
fore molecular amplification has increased target density 
and improved sensitivity of diagnostic tools such as quanti-
tative PCR (qPCR) or isolation in cell cultures (13). In line 
with these findings, we hypothesized that O. tsutsugamushi 
can survive and potentially grow in conventional hemocul-
ture media within the co-inoculated human host cells and 
that this capacity for growth could be used to improve di-
agnostic and analytical sensitivities.
The Study
We conducted this study at the Microbiology Laboratory, 
Mahosot Hospital, Vientiane, Laos, the only microbiology 
laboratory in Vientiane with a routine, accessible hemo-
culture service for sepsis diagnosis (4,14). Study patients 
provided written informed consent; ethical approval was 
granted by the Oxford Tropical Research Ethics Commit-
tee, University of Oxford (Oxford, UK), and the National 
Ethics Committee for Health Research, Laos.
One pair of hemocultures was incubated aerobically at 
35°C–37°C for 7 days. As part of a weekly routine molecu-
lar diagnostic service, admission EDTA anti-coagulated 
buffy coats (≈200 μL) from febrile patients were collected 
to test for O. tsutsugamushi and Rickettsia spp. by qPCR 
(11). Serial dilutions of plasmids (pGEM-T Vector Sys-
tems; Promega, Southhampton, UK) and nontemplate con-
trols were included in all runs as external controls; they al-
ways showed the appropriate result. During the 2014 rainy 
season (May–October), we collected consecutive hemocul-
ture fluids after 24 h of incubation (0.5 mL/bottle; total 1 
mL/patient; n = 760) (15). Each aliquot contained ≈0.1 mL 
blood or 0.01 mL buffy coat per mL media. If the EDTA 
buffy coat qPCR result (cycle quantitation value <40) was 
positive within the 7-day hemoculture incubation period (n 
= 11), the respective bottles were sampled at subsequent 
times so PCR positivity could be estimated (Table). 
Hemoculture fluids were centrifuged (10 min at 15,900 
× g) to pellet intracellular and extracellular bacteria, and 
DNA was extracted by using a method that removes inhibi-
tors with benzyl alcohol (guanidine hydrochloride lysis/
column extraction) (16). The same qPCR protocols were 
used for buffy coat (1 μL/reaction) and hemoculture fluids 
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(7 µL/reaction), with bovine serum albumin (40 μg/reac-
tion) added in the latter (11,13). We estimated bacterial 
loads using plasmid standard curves and calculated bacte-
rial multiplication factor by dividing bacterial numbers, at 
follow-up days, by the number in the first sample.
Of the 760 buffy coat samples, 21 were positive for O. 
tsutsugamushi by qPCR; therefore, to estimate survival and 
growth, we collected aliquots of hemoculture fluids dur-
ing days 1–7 (n = 11). During that period, 100/760 (13%) 
hemocultures were positive for other organisms; however, 
none of the known O. tsutsugamushi–infected patients 
were co-infected with an alternative pathogen. In addition, 
hemoculture fluids from the first 277 patients with buffy 
coats negative for O. tsutsugamushi by qPCR, underwent 
O. tsutsugamushi qPCR testing to explore whether us-
ing hemoculture fluids as an additional diagnostic sample 
could improve molecular detection of O. tsutsugamushi.
For nearly all (20/21) of the O. tsutsugamushi–positive 
patients, >1 hemoculture samples were available. Of these, 
>1 hemoculture sample from 17/20 (85%) patients tested 
positive (Table). Despite the initial 1:10 dilution of blood 
in hemoculture fluid, 66% (14/21) of patients with buffy 
coat–positive qPCR results also had a positive result in the 
first hemoculture fluid sample (Table). Due to logistical con-
straints, only 11/21 patients could be tested at multiple time 
points; samples from 7/11 (63%) showed a marked increase 
in O. tsutsugamushi density between day 1 and day 7 (Fig-
ure). The increase ranged from 2-fold to 210-fold (median 
3.25-fold), and data suggest that Orientia bacterial density 
peaked in the first 5 days and subsequently declined (Figure).
During the same period, 10/760 patients were diag-
nosed with Rickettsia spp. infection by blood culture qPCR. 
In contrast to the positive results for O. tsutsugamushi, all 
samples were negative by Rickettsia spp. hemoculture fluid 
qPCR, regardless of sampling day.
Of samples from the 277 patients tested for O. tsutsuga-
mushi in hemoculture fluid incubated for 24 h, those from an 
additional 3 patients, negative by qPCR at admission, were 
positive (cycle quantitation value <40). In this pilot study, 
combining buffy coat and hemoculture fluid testing, the 
number of O. tsutsugamushi–positive patients increased by 3 
(27%). Results are consistent with our hypothesis that qPCR 
on incubated hemoculture fluid alone or in combination with 
admission buffy coat testing could improve the sensitivity of 
molecular diagnosis of O. tsutsugamushi infection.
Conclusions
Our findings suggest that O. tsutsugamushi remains vi-
able and growing in hemoculture, presumably in human 
leukocytes. This observation opens up new possibilities 
for detecting O. tsutsugamushi and other intracellular 
organisms, albeit seemingly not Rickettsia spp. With the 
discovery of Orientia spp. outside the tsutsugamushi tri-
angle, improved tools are needed to aid the timely iden-
tification of infections in disease-endemic communities 
and among returning travelers to facilitate appropriate 
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Table. Results	of	testing	HCF	from	21	patients	whose	samples	had	tested	positive	for	Orientia tsutsugamushi by	qPCR	on	EDTA	buffy	
coat after >1	days	of	incubation,	Laos,	2014* 
Patient code 
Day of incubation of HCF† 
1 2 3 5 7 
29931 +	(Cq	34)     
30009 –     
30029 –     
30100 – (Cq	42)  – +	(Cq	35) +	(Cq	38) 
30104 +	(Cq	38)     
30316 +	(Cq	37)  –  +	(Cq	38) 
30329  +	(Cq39)  +	(Cq	35) +	(Cq	37) 
30379 +	(Cq	34)     
30416 +	(Cq	35)  +	(Cq40) +	(Cq	40)  
30442 –    – 
30446 +	(Cq	37)    – 
30581 –  +	(Cq32) +	(Cq	30) +	(Cq	34) 
30600 –    +	(Cq	32) 
30862 +	(Cq	33)     
30874 +	(Cq	30)     
30920      
31120 +	(Cq	31)     
31199 +	(Cq	30)     
31209 +	(Cq	31)    +	(Cq	21) 
31230 +	(Cq	31)   +	(Cq	31) +	(Cq	32) 
31231 +	(Cq	32)   +	(Cq	30) +	(Cq	37) 
*For	each	patient,	2	hemocultures bottles	were	used	(Pharmaceutical	Factory	No.	2,	Vientiane,	Laos):	1.7	g	tryptic	hydrolysate	casein,	0.3	g	soy	peptone,	
0.5	g	sodium	chloride,	0.25	g	potassium	phosphate,	0.25	g	dextrose,	0.025	g	sodium	polyanetholsulfonate/100	mL)	were	inoculated	with	blood	in	a	1:10	
dilution.	Cq,	cycle	quantitation;	HCF,	hemoculture	fluids;	qPCR,	quantitative	PCR;	–,	sample	available/negative;	+,	sample	available/positive;	blank	cell,	
no	sample	available.	 
†Cq	values	are	noted	in	parentheses	to	illustrate	the	increase	in	template. 
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treatment (4). In areas without sophisticated laboratory 
facilities, the combination of hemoculture amplification 
and direct diagnostic (e.g., antigen capture) has been pro-
posed for simplified Salmonella enterica serovar Typhi 
diagnosis and resistance molecular screening (13). Simi-
larly, innovative approaches to identify O. tsutsugamushi 
infections after >1 days could be developed. Because O. 
tsutsugamushi is categorized as a Hazard Group 3 patho-
gen, sampling and processing of hemocultures from pa-
tients with suspected scrub typhus should be conducted 
with appropriate biosafety precautions.
Furthermore, the possibility of using hemoculture as a 
simple transport tool for samples from remote areas should 
be investigated. Clinical isolates from remote areas can 
also show O. tsutsugamushi diversity, which can guide the 
development of diagnostic tests and vaccines (3).
The underlying mechanisms and the reason O. tsu-
tsugamushi, but not Rickettsia spp., grows in hemoculture 
fluid are unclear. We compared the diagnostic possibilities 
of preincubating blood samples in hemoculture fluid before 
qPCR with using qPCR on buffy coat samples to investi-
gate its advantage as a diagnostic tool. Further investiga-
tions are needed to confirm our findings, explore whether 
O. tsutsugamushi really multiplies in hemoculture fluids, 
and assess multiplication rates of host cells and pathogens 
in these fluids. Such studies can provide evidence for the 
optimal system and number of incubation days that would 
maximize the effects for the O. tsutsugamushi diagnostic. 
These findings could also affect the detection of other un-
derdiagnosed intracellular pathogens that scientists assume 
cannot be detected in hemoculture fluids.
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